HEPATITIS C VIRUS INHIBITORS

The present disclosure relates to the preparation of a compound for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pyrrolidinyl or biphenyl derivatives which are used in a process for preparing the HCV inhibiting compound.

Saved in:
Bibliographic Details
Main Authors GOODRICH Jason, LANGLEY David R, MARTEL Alain, HAMANN Lawrence G, JAMES Clint A, RUEDIGER Edward H, WANG Gan, YANG Fukang, MEANWELL Nicholas A, ST. LAURENT Denis R, GOOD Andrew C, ROMINE Jeffrey Lee, SNYDER Lawrence B, BACHAND Carol, NGUYEN Van N, LAVOIE Rico, DEON Daniel H, BELEMA Makonen, LOPEZ Omar D
Format Patent
LanguageEnglish
Slovenian
Published 29.06.2018
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to the preparation of a compound for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pyrrolidinyl or biphenyl derivatives which are used in a process for preparing the HCV inhibiting compound.
Bibliography:Application Number: SI20070032006T